Staphylococcus aureus surgical site infection rates in 5 European countries
oleh: Sibylle C. Mellinghoff, Caroline Bruns, Markus Albertsmeier, Juliane Ankert, Louis Bernard, Sofia Budin, Camille Bataille, Annika Y. Classen, Florian B. Cornely, Elodie Couvé-Deacon, Maria Fernandez Ferrer, Jesús Fortún, Alicia Galar, Eva Grill, Thomas Guimard, Jürgen A. Hampl, Sebastian Wingen-Heimann, Juan P. Horcajada, Felix Köhler, Carolin Koll, Joan Mollar, Patricia Muñoz, Mathias W. Pletz, Jule Rutz, Jon Salmanton-García, Harald Seifert, Ferdinand Serracino-Inglott, Alex Soriano, Jannik Stemler, Janne J. Vehreschild, Tim O. Vilz, Jan-Hendrik Naendrup, Oliver A. Cornely, Blasius J. Liss
| Format: | Article |
|---|---|
| Diterbitkan: | BMC 2023-09-01 |
Deskripsi
Abstract Objective To determine the overall and procedure-specific incidence of surgical site infections (SSI) caused by Staphylococcus aureus (S. aureus) as well as risk factors for such across all surgical disciplines in Europe. Methods This is a retrospective cohort of patients with surgical procedures performed at 14 European centres in 2016, with a nested case–control analysis. S. aureus SSI were identified by a semi-automated crossmatching bacteriological and electronic health record data. Within each surgical procedure, cases and controls were matched using optimal propensity score matching. Results A total of 764 of 178 902 patients had S. aureus SSI (0.4%), with 86.0% of these caused by methicillin susceptible and 14% by resistant pathogens. Mean S. aureus SSI incidence was similar for all surgical specialties, while varying by procedure. Conclusions This large procedure-independent study of S. aureus SSI proves a low overall infection rate of 0.4% in this cohort. It provides proof of principle for a semi-automated approach to utilize big data in epidemiological studies of healthcare-associated infections. Trials registration The study was registered at clinicaltrials.gov under NCT03353532 (11/2017).